免疫抑制患者的鼻腔下呼吸道感染:一个队列研究
Luis Felipe Reyes1,2,3, Natalia Sanabria-Herrera4,5, Saad Nseir6
1Unisabana Center for Translational Science, School of Medicine, Universidad de La Sabana, Chia, Colombia. luis.reyes5@unisabana.edu.co.
Annals of intensive care
|May 6, 2025
概括
患有临床下呼吸道感染 (nLRTI) 的免疫抑制患者面临较低的存活率和更高的风险. 这些发现突出了弱势患者群体结果的关键差异.
科学领域:
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
- 流行病学 流行病学
背景情况:
- 鼻腔下呼吸道感染 (nLRTI) 在重症监护病房 (ICU) 存在重大风险.
- 了解免疫抑制患者与非免疫抑制患者的结果对于有针对性的干预至关重要.
- 以前的研究还没有完全阐明这些患者群体之间的nLRTI的特定临床和微生物学差异.
研究的目的:
- 为了比较免疫抑制和非免疫抑制的ICU患者的临床特征,微生物学和nLRTI的结果.
- 为了确定患有nLRTI的患者死亡的风险因素.
- 确定nLRTI免疫抑制患者中最常见的病原体.
主要方法:
- 一项涉及1,060名患有nLRTI的成年ICU患者的跨国多中心研究的后期分析.
- 描述性统计数据用于比较患者特征和病原体分布.
- 根据疾病严重程度 (SAPS II) 和其他临床变量进行调整,以评估28天死亡风险.
主要成果:
- 免疫抑制,通常是由于瘤疾病,在24.9%的患者中存在.
- Pseudomonas aeruginosa 是主要的病原体,特别是在免疫抑制患者 (25.3% vs 16.7%).
- 较高的疾病严重程度和急性生理学评分II (SAPS II) 独立预测死亡率 (HR:1.023). 血液性恶性瘤,化疗和骨髓移植增加了免疫抑制患者的死亡风险.
结论:
- 与非免疫抑制患者相比,患有nLRTI的免疫抑制患者的调整后生存概率明显较低.
- Pseudomonas aeruginosa 是在患有nLRTI的免疫抑制患者中发现的最常见的病原体.
- 特定的疾病,如血液性恶性瘤,在这个脆弱的人群中增加了死亡风险.
相关概念视频
Pneumonia I: Introduction
188
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
188
Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
Pulmonary Tuberculosis I
208
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
208
Drugs Used in Lower Respiratory Disorders: Overview
247
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
247
Immunodeficiency Diseases
833
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
833
Factors Affecting the Risk of Infection
10.6K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
10.6K


